Reasons associated with treatment non-adherence in schizophrenia in a Pakistan cohort

Asian Journal of Psychiatry

Volumn 30, Issue , 2017, Pages 39-43

  Ahmad, Irshad ^a   Khalily, Muhammad Tahir ^a   Hallahan, Brian ^b  

^a INTERNATIONAL ISLAMIC UNIVERSITY   (Pakistan)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Pharmacotherapy; Psychotic relapse; Schizophrenia; Treatment non adherence

Indexed keywords

NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; ADVERSE DRUG REACTION; ARTICLE; COHORT ANALYSIS; CULTURAL FACTOR; FEMALE; HUMAN; INTROSPECTION; MAJOR CLINICAL STUDY; MALE; PAKISTAN; POVERTY; PRIORITY JOURNAL; PSYCHOEDUCATION; RELAPSE; SCHIZOPHRENIA; SPIRITUAL HEALING; SUBSTANCE USE; TREATMENT REFUSAL; ETHNOLOGY; MEDICATION COMPLIANCE; MIDDLE AGED; PSYCHOSIS; RECURRENT DISEASE; YOUNG ADULT;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PAKISTAN; PSYCHOTIC DISORDERS; RECURRENCE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 85025068021     PISSN: 18762018     EISSN: 18762026     Source Type: Journal    
DOI: 10.1016/j.ajp.2017.07.024     Document Type: Article

References (52)

1. Ahmad, I., Khalily, M.T., Hallahan, B., Shah, I., Factors associated with psychotic relapse in patients with schizophrenia in a Pakistani cohort. Int. J. Ment. Health Nurs. 26 (2017), 384–390.
2. Amr, M., El-Mogy, A., Shams, T., 2655-Adherence in egyptian patients with schizophrenia: the role of insight, medication beliefs and spirituality. Eur. Psychiatry, 28, 2013, 1.
3. Awad, A.G., Voruganti, L.N., The burden of schizophrenia on caregivers. Pharmacoeconomics 26 (2008), 149–162.
4. Barkhof, E., Meijer, C.J., De Sonneville, L.M., Linszen, D.H., De Haan, L., Interventions to improve adherence to antipsychotic medication in patients with schizophrenia-a review of the past decade. Eur. Psychiatry 27 (2012), 9–18.
5. Bradshaw, T., Pedley, R., Evolving role of mental health nurses in the physical health care of people with serious mental health illness. Int. J. Ment. Health Nurs. 21 (2012), 266–273.
6. Chandra, I.S., Kumar, K.L., Reddy, M.P., Reddy, C.M.P.K., Attitudes toward medication and reasons for non-compliance in patients with schizophrenia. Indian J. Psychol. Med., 36, 2014, 294.
7. Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W.F., Möller, H.-J., Schizophrenia, W.T.F.O.T.G.F., Falkai, P., Wobrock, T., Lieberman, J., World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia: part 1: acute treatment of schizophrenia. World J. Biol. Psychiatry 6 (2005), 132–191.
8. Gutiérrez-Casares, J.R., Cañas, F., Alonso-Escolano, D., Hidalgo-Borrajo, R., Rodríguez-Morales, A., Adherence to treatment and therapeutic strategies in schizophrenic patients: the ADHERE study. CNS Spectr. 15 (2010), 327–338.
9. Haddad, P.M., Brain, C., Scott, J., Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Relat. Outcome Meas. 5 (2014), 43–62.
10. IBM SPSS Statistics For Windows, V. A., NY, 2013.
11. Insel, T.R., Rethinking schizophrenia. Nature 468 (2010), 187–193.
12. Ioasa-Martin, I., Moore, L.J., Problems with non-adherence to antipsychotic medication in Samoan New Zealanders: a literature review. Int. J. Ment. Health Nurs. 21 (2012), 386–392.
13. Johnsdotter, S., Ingvarsdotter, K., Östman, M., Carlbom, A., Koran reading and negotiation with jinn: strategies to deal with mental ill health among Swedish Somalis. Mental Health Religion Culture 14:8 (2011), 741–755.
14. Kane, J.M., Treatment strategies to prevent relapse and encourage remission. J. Clin. Psychiatry 68 (2006), 27–30.
15. Kay, S.R., Flszbein, A., Opfer, L.A., The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull., 13, 1987, 261.
16. Kazadi, N., Moosa, M., Jeenah, F., Factors associated with relapse in schizophrenia. S. Afr. J. Psychiatry 14 (2008), 52–62.
17. Kennedy, J., Coyne, J., Sclar, D., Drug affordability and prescription noncompliance in the United States: 1997–2002. Clin. Ther. 26 (2004), 607–614.
18. Khalifa, N., Hardie, T., Latif, S., Jamil, I., Walker, D.M., Beliefs about Jinn, black magic and the evil eye among Muslims: age, gender and first language influences. Int. J. Culture Mental Health 4:1 (2011), 68–77.
19. Knapp, M., Costs of schizophrenia. Br. J. Psychiatry 171 (1997), 509–518.
20. Laursen, T.M., Munk-Olsen, T., Vestergaard, M., Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr. Opin. Psychiatry 25 (2012), 83–88.
21. Li, Z., Arthur, D., Family education for people with schizophrenia in Beijing: China. Br. J. Psychiatry 187 (2005), 339–345.
22. Literacy Rate Of Education In Pakistan. 2015. Available: http://www.archivistonline.pk/literacy-rate-in-pakistan.
23. Macaluso, M., Mcknight, S., Overcoming medication nonadherence in schizophrenia: strategies that can reduce harm: dosing strategies, direct inquiry, psychoeducation can improve outcomes. Curr. Psychiatry, 12, 2013, 14.
24. Marcus, S.C., Zummo, J., Pettit, A.R., Stoddard, J., Doshi, J.A., Antipsychotic adherence and rehospitalization in schizophrenia patients receiving oral versus long-acting injectable antipsychotics following hospital discharge. J. Managed Care Specialty Pharm. 21 (2015), 754–769.
25. McCabe, R., Bullenkamp, J., Hansson, L., Lauber, C., Martinez-Leal, R., Rössler, W., Salize, H.J., Svensson, B., Torres-Gonzalez, F., Van Den Brink, R., The therapeutic relationship and adherence to antipsychotic medication in schizophrenia. PLoS One, 7, 2012, e36080.
26. Morken, G., Widen, J.H., Grawe, R.W., Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia. BMC Psychiatry, 8, 2008, 32.
27. Mueser, K.T.M., McGurk, Susan R., Schizophrenia. Lancet 363 (2004), 2063–2072.
28. Nosé, M., Barbui, C., Gray, R., Tansella, M., Clinical interventions for treatment non-adherence in psychosis: meta-analysis. Br. J. Psychiatry 183 (2003), 197–206.
29. Nose, M., Barbui, C., Tansella, M., How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychol. Med. 33 (2003), 1149–1160.
30. Olfson, M., Mechanic, D., Hansell, S., Boyer, C.A., Walkup, J., Weiden, P.J., Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr. Serv. 51 (2000), 216–222.
31. Olivares, J., Rodriguez-Morales, A., Diels, J., Povey, M., Jacobs, A., Zhao, Z., Lam, A., Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR). Eur. Psychiatry 24 (2009), 287–296.
32. Olivares, J.M., Pinal, B., Cinos, C., Comparison of long-acting antipsychotic injection and oral antipsychotics in schizophrenia. Neuropsychiatry 1 (2011), 275–289.
33. PAYCHECKPK 2015. Paycheckpk.
34. Panhwar, F., Schizophrenia in Pakistan [Online]. 2014 Available: http://www.pkhope.com/author/panhwar.
35. Pilling, S., Bebbington, P., Kuipers, E., Garety, P., Geddes, J., Orbach, G., Morgan, C., Psychological treatments in schizophrenia: i. Meta-analysis of family intervention and cognitive behaviour therapy. Psychol. Med. 32 (2002), 763–782.
36. Rababa'h, S., Alhmoud, N., Partial adherence with antipsychotic medications and factors related to medication relapse in Jordanian patients with schizophrenia. Eur. Sci. J. ESJ, 9, 2013.
37. Rao, M.H., Soomro, I.B.M., Non-compliance-awareness and attitude of psychiatric patients regarding out patient follow-up at Civil Hospital, Karachi. J. Dow. Uni. Health Sci. 2 (2008), 36–40.
38. Robinson, D., Woerner, M.G., Alvir, J.M.J., Bilder, R., Goldman, R., Geisler, S., Koreen, A., Sheitman, B., Chakos, M., Mayerhoff, D., Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch. Gen. Psychiatry 56 (1999), 241–247.
39. Sajatovic, M., Blow, F.C., Kales, H.C., Valenstein, M., Ganoczy, D., Ignacio, R.V., Age comparison of treatment adherence with antipsychotic medications among individuals with bipolar disorder. Int. J. Geriatr. Psychiatry 22 (2007), 992–998.
40. San-Molina, L., Rubio, G., Bernardo-Fernández, I., Miguélez-Fernández, S., P03-180-Reasons for relapses in patients with schizophrenia admitted to acute units. Eur. Psychiatry, 26, 2011, 1349.
41. Sariah, A.E., Outwater, A.H., Malima, K.I., Risk and protective factors for relapse among individuals with schizophrenia: a qualitative study in Dar es Salaam, Tanzania. BMC Psychiatry, 14, 2014, 240.
42. Taj, R., Khan, S., A study of reasons of non-compliance to psychiatric treatment. Dementia, 2(0.5), 2005.
43. Taj, F., Tanwir, M., Aly, Z., Khowajah, A.A., Tariq, A., Syed, F.K., Waqar, F., Shahzada, K., Factors associated with non-adherence among psychiatric patients at a tertiary care hospital, Karachi, Pakistan: a questionnaire based cross-sectional study. J. Pak Med. Assoc, 58, 2008, 432.
44. Teferra, S., Hanlon, C., Beyero, T., Jacobsson, L., Shibre, T., Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers. BMC Psychiatry, 13, 2013, 168.
45. Tharani, A.J., Farooq, S., Saleem, F., Naveed, A., Compliance to antipsychotic medication: a challenge for client, family and health care providers. J. Pak. Med. Assoc. 63 (2013), 516–518.
46. Turkington, D., Kingdon, D., Rathod, S., Hammond, K., Pelton, J., Mehta, R., Outcomes of an effectiveness trial of cognitive-behavioural intervention by mental health nurses in schizophrenia. Br. J. Psychiatry 189 (2006), 36–40.
47. Üçok, A., Polat, A., Çakır, S., Genç, A., One year outcome in first episode schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 256 (2006), 37–43.
48. Valenstein, M., Kavanagh, J., Lee, T., Reilly, P., Dalack, G.W., Grabowski, J., Smelson, D., Ronis, D.L., Ganoczy, D., Woltmann, E., Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness. Schizophr. Bull. 37 (2011), 727–736.
49. Vos, T., Barber, R.M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 386, 2015, 743.
50. Waterreus, A., Morgan, V.A., Castle, D., Galletly, C., Jablensky, A., Di Prinzio, P., Shah, S., Medication for psychosis-consumption and consequences: the second Australian national survey of psychosis. Aust. N. Z. J. Psychiatry 46 (2012), 762–773.
51. World Health Organization Europe 2014. Mental Health Data and Statistics.
52. Yamada, K., Watanabe, K., Nemoto, N., Fujita, H., Chikaraishi, C., Yamauchi, K., Yagi, G., Asai, M., Kanba, S., Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study. Psychiatry Res. 141 (2006), 61–69.